Friday, 22 March 2019
Latest news
Main » Acadia Healthcare (ACHC) Shares Sold by Metropolitan Life Insurance Co. NY

Acadia Healthcare (ACHC) Shares Sold by Metropolitan Life Insurance Co. NY

09 April 2018

The ratio dropped, as 120 funds increased and opened new stock positions, while 130 decreased and sold equity positions in Acadia Healthcare Company Inc. The funds in our database now hold: 104.36 million shares, down from 107.79 million shares in 2017Q3. Eagle Boston Investment Management Inc has cut its stake in Advanced Energy Industries (NASDAQ:AEIS) and also reduced its holding in Arcbest Corp (NASDAQ:ARCB) by 88,169 shares in the quarter, for a total of 242,735 shares. It turned negative, as 54 investors sold ACHC shares while 76 reduced holdings. Corporate investors have N/A stake in the business as Beta Factor, which is commonly used to evaluate perils of the safety measures, was 0.62. The stock was sold at an average price of $38.67, for a total transaction of $5,800,500.00. After having $0.61 EPS previously, Acadia Healthcare Company, Inc.'s analysts see -22.95% EPS growth. Darling Ingredients Inc now has $2.86 billion valuation. The volatility in the previous week has experienced by 3.00% and observed of 2.80% in the previous month.

On Thursday, Shares of Acadia Healthcare Company Inc (NASDAQ: ACHC) 1.77% and ended its trading session at $40.71.

ACHC had 6 selling transactions and 0 insider purchases since December 15, 2017. A company that manages their assets well will have a higher return, while a company that manages their assets poorly will have a lower return. (NASDAQ:ACHC) on Tuesday, September 5 with "Buy" rating. Insiders own 11.10% of the company's stock. (NASDAQ:ACHC) shs were sold by GOLDBERG RANDALL P. Fund Evaluation Grp Ltd Liability has invested 0.1% in Acadia Healthcare Company, Inc. (NASDAQ:ACHC) has "Outperform" rating given by BMO Capital Markets. On Wednesday, January 4 the stock rating was initiated by Citigroup with "Buy".

The Price to book ratio is the current share price of a company divided by the book value per share. Frontier Capital Management Co. Old Mutual Customised Solutions (Proprietary) Limited, a South Africa-based fund reported 21,112 shares. The Company focuses on acquiring and developing behavioral healthcare facilities.

ACHC has been the topic of a number of analyst reports. The company reported $0.61 earnings per share (EPS) for the quarter, beating the Zacks' consensus estimate of $0.54 by $0.07. This means that if you believe the current share price should move towards its intrinsic value over time, a low beta could suggest it is not likely to reach that level anytime soon, and once it's there, it may be hard to fall back down into an attractive buying range again. Supplemental Annuity Collective Trust Of Nj has 0.33% invested in Acadia Healthcare Company, Inc.

Acadia Healthcare Company, Inc. develops and operates inpatient psychiatric facilities, residential treatment centers, group homes, substance abuse facilities, and outpatient behavioral healthcare facilities to serve the behavioral health and recovery needs of communities in the United States, the United Kingdom, and Puerto Rico. Information in this release is fact checked and produced by competent editors of Stocks Market Cap; however, human error can exist. It is derived from the P/E - Price Earnings Ratio, in which the profit is replaced by cash flow. It also provides outpatient community services, such as community programs that are created to provide therapeutic treatment to children and adolescents who have a clinically-defined emotional, psychiatric, or chemical dependency disorder. Since ACHC is now undervalued, it may be a great time to increase your holdings in the stock. The company's stock had a trading volume of 435,505 shares, compared to its average volume of 865,332. Guernsey-based Bluecrest Capital Management Ltd has invested 0.06% in Acadia Healthcare Company, Inc. (ACHC) has declined 11.29% since April 8, 2017 and is downtrending. It has underperformed by 22.84% the S&P500. This's net activity of $13.14 million. 5,102 shares were sold by FOSTER JAMES C, worth $551,176. (NYSE:CRL) was sold by Girshick Birgit on Tuesday, March 6. Rendle Steven E also sold $4.63M worth of V.F. Corporation (NYSE:VFC) shares. Shares for $250,741 were sold by Barbo William D on Wednesday, February 21. Research analysts often publish stock price targets along with buy-sell recommendations. Therefore 44% are positive. Acadia Healthcare had 53 analyst reports since August 6, 2015 according to SRatingsIntel. The company was maintained on Tuesday, October 24 by UBS. (NASDAQ:ACHC) has "Neutral" rating given by Credit Suisse. (NYSE:CRL) has "Neutral" rating given on Friday, December 16 by Goldman Sachs. (NYSE:CRL) earned "Equal Weight" rating by Barclays Capital on Wednesday, November 30. The stock has "Hold" rating by KeyBanc Capital Markets on Thursday, October 12. (NYSE:CRL) rating on Wednesday, March 14. (NYSE:DAR) earned "Overweight" rating by JP Morgan on Thursday, May 26. (NASDAQ:ACHC) has "Buy" rating given by Jefferies. The firm has "Neutral" rating given on Monday, October 30 by Mizuho. (NYSE:CRL) has "Underweight" rating given on Friday, May 20 by Barclays Capital. It also upped Cognex Corp (NASDAQ:CGNX) stake by 45,643 shares and now owns 100,698 shares. Tg Therapeutics Inc (NASDAQ:TGTX) was raised too.

Analysts await Charles River Laboratories International, Inc.

Optimism over first-quarter earnings increased, with JPMorgan Chase (JPM) and other financials expected to kick off the reporting period next week. During the same period a year ago, the firm posted $0.59 earnings per share. CRL's profit will be $59.94M for 20.47 P/E if the $1.25 EPS becomes a reality.

- Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.